Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63 - PubMed (original) (raw)

. 2002 Apr 1;11(7):799-804.

doi: 10.1093/hmg/11.7.799.

Affiliations

• PMID: 11929852
• DOI: 10.1093/hmg/11.7.799

Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63

Pascal H G Duijf et al. Hum Mol Genet. 2002.

Abstract

The transcriptional co-activator p63 is of crucial importance for correct development of the limbs, ectodermal appendages (skin, nails, teeth, hair, glands), lip and palate. Mutations in the p63 gene are found in a number of human syndromes, including ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome, limb-mammary syndrome (LMS), Hay-Wells syndrome and in non-syndromic split-hand/split-foot malformation (SHFM). Each syndrome has a specific pattern of mutations with different functional effects in in vitro functional assays. We report a mutation R298Q in acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome, another EEC-like condition. The mutation is located in the DNA binding domain of p63, which harbors almost all EEC associated mutations. However, unlike mutations in EEC syndrome, the R298Q ADULT syndrome mutation does not impair DNA binding. Rather, the mutation confers novel transcription activation capacity on the DeltaN-p63gamma isoform, which normally does not possess such activity. These results confirm that ADULT syndrome is a clinically as well as molecularly distinct member of the expanding p63 mutation family of human malformation syndromes. Our results further show that p63 contains a second transactivation domain which is normally repressed and can become activated by mutations in the DNA binding domain of p63.

PubMed Disclaimer

Similar articles

• Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
  McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton DJ, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H. McGrath JA, et al. Hum Mol Genet. 2001 Feb 1;10(3):221-9. doi: 10.1093/hmg/10.3.221. Hum Mol Genet. 2001. PMID: 11159940
• p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation.
  van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG. van Bokhoven H, et al. Am J Hum Genet. 2001 Sep;69(3):481-92. doi: 10.1086/323123. Epub 2001 Jul 17. Am J Hum Genet. 2001. PMID: 11462173 Free PMC article.
• Ectodermal dysplasias: the p63 tail.
  Tadini G, Santagada F, Brena M, Pezzani L, Nannini P. Tadini G, et al. G Ital Dermatol Venereol. 2013 Feb;148(1):53-8. G Ital Dermatol Venereol. 2013. PMID: 23407076
• P63 gene mutations and human developmental syndromes.
  Brunner HG, Hamel BC, Bokhoven Hv Hv. Brunner HG, et al. Am J Med Genet. 2002 Oct 15;112(3):284-90. doi: 10.1002/ajmg.10778. Am J Med Genet. 2002. PMID: 12357472 Review.
• The p63 gene in EEC and other syndromes.
  Brunner HG, Hamel BC, Van Bokhoven H. Brunner HG, et al. J Med Genet. 2002 Jun;39(6):377-81. doi: 10.1136/jmg.39.6.377. J Med Genet. 2002. PMID: 12070241 Free PMC article. Review.

Cited by

• Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63.
  Zarnegar BJ, Webster DE, Lopez-Pajares V, Vander Stoep Hunt B, Qu K, Yan KJ, Berk DR, Sen GL, Khavari PA. Zarnegar BJ, et al. Am J Hum Genet. 2012 Sep 7;91(3):435-43. doi: 10.1016/j.ajhg.2012.07.007. Epub 2012 Aug 23. Am J Hum Genet. 2012. PMID: 22922031 Free PMC article.
• Modeling AEC-New approaches to study rare genetic disorders.
  Koch PJ, Dinella J, Fete M, Siegfried EC, Koster MI. Koch PJ, et al. Am J Med Genet A. 2014 Oct;164A(10):2443-54. doi: 10.1002/ajmg.a.36455. Epub 2014 Mar 24. Am J Med Genet A. 2014. PMID: 24665072 Free PMC article. Review.
• The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
  Ben Khalifa Y, Teissier S, Tan MK, Phan QT, Daynac M, Wong WQ, Thierry F. Ben Khalifa Y, et al. PLoS Pathog. 2011 Sep;7(9):e1002256. doi: 10.1371/journal.ppat.1002256. Epub 2011 Sep 29. PLoS Pathog. 2011. PMID: 21980285 Free PMC article.
• A double dealing tale of p63: an oncogene or a tumor suppressor.
  Chen Y, Peng Y, Fan S, Li Y, Xiao ZX, Li C. Chen Y, et al. Cell Mol Life Sci. 2018 Mar;75(6):965-973. doi: 10.1007/s00018-017-2666-y. Epub 2017 Oct 3. Cell Mol Life Sci. 2018. PMID: 28975366 Free PMC article. Review.
• Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.
  Pecorari R, Bernassola F, Melino G, Candi E. Pecorari R, et al. Biochem J. 2022 Jun 30;479(12):1375-1392. doi: 10.1042/BCJ20210737. Biochem J. 2022. PMID: 35748701 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • The Weizmann Institute of Science GeneCards and MalaCards databases

• Miscellaneous

  • NCI CPTAC Assay Portal